Back to CITIGROUP INC CITIGROUP INC

INBXINBX
Showing 8 of 9 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in INHIBRX BIOSCIENCES INC

Yes. Citigroup holds 75,721 shares of INBX (Inhibrx Biosciences), worth $7.2M, as of its Q2 2026 13F filing. It increased the position by 13,205 shares (+21.1%) from Q1 2026. Citigroup has held INBX in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$7.2M

Current Shares

75,721

Total Value Change

+$7M

Total Shares Change

+66,421

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
75,721
+21.1%
$7.2M0.0%$94.75
33
2026-Q1
Increased
62,516
+12.1%
$4.2M0.0%$74.33
30
2025-Q4
Increased
55,759
+1021.7%
$4.4M0.0%$77.98
43
2025-Q3
Increased
4,971
+49.2%
$167,4230.0%$32.31
31
2025-Q2
Decreased
3,332
-60.8%
$47,5470.0%$14.43
0
2025-Q1
Decreased
8,509
-14.7%
$119,0410.0%$14.12
0
2024-Q4
Increased
9,973
+7.2%
$153,5840.0%$15.14
24
2024-Q3
Increased
9,300
+121.8%
$145,6380.0%$15.52
36

Other major holders of INBX: MORGAN STANLEY, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used